Looking for Polysorbate 20 pharmaceutical excipients? Find information on Polysorbate 20's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Polyoxyethylene 20 sorbitan monolaurate
Polysorbate 20 is classified as an "inactive ingredient or pharmaceutical necessity" in topical analgesic, antirheumatic, otic, burn, and sunburn treatment/prevention products.

SUPPLIERS

read-more
read-more

01

Hubei Gedian Humanwell Pharmaceuti...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.

Flag China
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Hubei Gedian Humanwell Pharmaceutical

02

Nanjing Well Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Flag China
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Nanjing Well Pharmaceutical
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.

Flag China
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38299

Submission : 2023-07-26

Status : Active

Type : IV

Hubei Gedian Humanwell Pharmaceutical

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Flag China
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 36565

Submission : 2022-07-05

Status : Active

Type : IV

Nanjing Well Pharmaceutical
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDA Dossiers

read-more
read-more

01

Dosage Form : SUSPENSION, LIQUID

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : SUSPENSION, LIQUID

USA
arrow
Formnext Forum
Not Confirmed

Route : AURICULAR (OTIC)

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 0.1

Potency Unit : %

blank

02

Dosage Form : INJECTION

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : INJECTION

USA
arrow
Formnext Forum
Not Confirmed

Route : IM - SC

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 0.0005

Potency Unit : %

blank

03

Dosage Form : INJECTION

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : INJECTION

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 0

Potency Unit : NA

blank

04

Dosage Form : INJECTION, SUSPENSION, EXTENDE...

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : INJECTION, SUSPENSION, EXTENDE...

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 0.5

Potency Unit : %

blank

05

Dosage Form : POWDER, FOR INJECTION SOLUTION...

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : POWDER, FOR INJECTION SOLUTION...

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 0.01

Potency Unit : %

blank

06

Dosage Form : SOLUTION, INJECTION

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : SOLUTION, INJECTION

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 0.029

Potency Unit : %W/V

blank

07

Dosage Form : SUSPENSION, EXTENDED RELEASE

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : SUSPENSION, EXTENDED RELEASE

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 1

Potency Unit : %

blank

08

Dosage Form : SUSPENSION, EXTENDED RELEASE

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : SUSPENSION, EXTENDED RELEASE

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 1

Potency Unit : %W/V

blank

09

Dosage Form : SUSPENSION, INJECTION

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : SUSPENSION, INJECTION

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAMUSCULAR

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 1.8

Potency Unit : %

blank

10

Dosage Form : INJECTION

POLYSORBATE 20
arrow
Formnext Forum
Not Confirmed

Dosage Form : INJECTION

USA
arrow
Formnext Forum
Not Confirmed

Route : INTRAVENOUS

CAS : 9005645

UNII : 7T1F30V5YH

Potency Amount : 4.8

Potency Unit : %

blank
click full view

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Surfactant Foaming Agents

read-more
read-more

Thickeners And Stabilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

MARKET PLACE

Do you need sourcing support? Ask us

EXCIPIENTS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty